DTE

26.89

+0.22%↑

RWE

43.12

-0.78%↓

EOAN

15.01

-3.07%↓

FORTUM.FI

18.05

+0.95%↑

EDP

3.715

-1.8%↓

DTE

26.89

+0.22%↑

RWE

43.12

-0.78%↓

EOAN

15.01

-3.07%↓

FORTUM.FI

18.05

+0.95%↑

EDP

3.715

-1.8%↓

DTE

26.89

+0.22%↑

RWE

43.12

-0.78%↓

EOAN

15.01

-3.07%↓

FORTUM.FI

18.05

+0.95%↑

EDP

3.715

-1.8%↓

DTE

26.89

+0.22%↑

RWE

43.12

-0.78%↓

EOAN

15.01

-3.07%↓

FORTUM.FI

18.05

+0.95%↑

EDP

3.715

-1.8%↓

DTE

26.89

+0.22%↑

RWE

43.12

-0.78%↓

EOAN

15.01

-3.07%↓

FORTUM.FI

18.05

+0.95%↑

EDP

3.715

-1.8%↓

Kodu・Aktsiate loetelu・STRATEC Biomedical AG

STRATEC Biomedical AG

Suletud

21.6

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

21.4

Max

22.1

Põhinäitajad
By Trading Economics
Sissetulek	2.8M 4.1M
Müük	-2.3M 57M
P/E Sektori keskmine	17.874 22.644
Aktsiakasum	0.124
Dividenditootlus	2.62
Kasumimarginaal	7.198
Töötajad	1,420
EBITDA	-16M 7.5M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+54.55% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.62% 3.26%

Turustatistika
By TradingEconomics
Turukapital	-25M 276M
Eelmine avamishind	21.6
Eelmine sulgemishind	21.6

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

N/A / 24.5 Toetus ja vastupanu

STRATEC Biomedical AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. juuli 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Võrdlus sarnastega

Hinnamuutus

STRATEC Biomedical AG Prognoos

Hinnasiht

By TipRanks

54.55% tõus

12 kuu keskmine prognoos

Keskmine 34 EUR 54.55%

Kõrge 46 EUR

Madal 27 EUR

Põhineb 4 Wall Streeti analüütiku instrumendi STRATEC Biomedical AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi STRATEC Biomedical AG aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 24.5Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.